TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones

Claudie Hooper, Mahvash Tavassoli, J. Paul Chapple, Dafe Uwanogho, Richard Goodyear, Gerry Melino, Simon Lovestone, Richard Killick

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

p73, like Notch, has been implicated in neurodevelopment and in the maintenance of the mature central nervous system. In this study, by the use of reporter-gene assays, we demonstrate that C-promoter binding factor-1 (CBF-1)-dependent gene transcription driven by the Notch-1 intracellular domain (N1ICD) is potently antagonized by exogenously expressed transactivating (TA) p73 splice variants in SH-SY5Y neuroblastomas and in primary neurones. Time course analysis indicated that the inhibitory effects of TAp73 are direct and are not mediated via the product of a downstream target gene. We found that endogenous TAp73 stabilized by either c-Abl or cisplatin treatment also potently antagonized N1ICD/CBF-1-dependent gene transcription. Furthermore, western blotting revealed that exogenous TAp73 suppressed endogenous hairy and enhancer of split-1 (HES-1) protein levels and antagonized the increase in HES-1 protein induced by exogenous N1ICD expression. Evidence of a direct physical interaction between N1ICD and TAp73α was demonstrated by co-immunoprecipitation. Using Notch deletion constructs, we demonstrate that TAp73α binds the N1ICD in a region C-terminal of aa 2094. Interestingly, ΔNp73α and TAp73αR292H also co-purified with N1ICD, but neither inhibited N1ICD/CBF-1-dependent transcription. This suggests that an intact transactivation (TA) domain and the ability to bind DNA are necessary for TAp73 to antagonize Notch signalling. Finally we found that TAp73α reversed the N1ICD-mediated repression of retinoic acid-induced differentiation of SH-SY5Y neuroblastomas, providing functional evidence for an inhibitory effect of TAp73α on notch signalling. Collectively, these findings may have ramifications for neurodevelopment, neurodegeneration and oncogenesis.

Original languageEnglish
Pages (from-to)989-999
Number of pages11
JournalJournal of Neurochemistry
Volume99
Issue number3
DOIs
Publication statusPublished - Nov 2006

Fingerprint

Neuroblastoma
Neurons
Protein Isoforms
Transcription
Genes
Tretinoin
Reporter Genes
Immunoprecipitation
Cisplatin
Transcriptional Activation
Carcinogenesis
Neurology
Central Nervous System
Western Blotting
Maintenance
Assays
Proteins
DNA
Transcription Factor HES-1

Keywords

  • Development
  • Neurodegeneration
  • Notch
  • Oncogenesis
  • p53
  • p73

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones. / Hooper, Claudie; Tavassoli, Mahvash; Chapple, J. Paul; Uwanogho, Dafe; Goodyear, Richard; Melino, Gerry; Lovestone, Simon; Killick, Richard.

In: Journal of Neurochemistry, Vol. 99, No. 3, 11.2006, p. 989-999.

Research output: Contribution to journalArticle

Hooper, C, Tavassoli, M, Chapple, JP, Uwanogho, D, Goodyear, R, Melino, G, Lovestone, S & Killick, R 2006, 'TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones', Journal of Neurochemistry, vol. 99, no. 3, pp. 989-999. https://doi.org/10.1111/j.1471-4159.2006.04142.x
Hooper, Claudie ; Tavassoli, Mahvash ; Chapple, J. Paul ; Uwanogho, Dafe ; Goodyear, Richard ; Melino, Gerry ; Lovestone, Simon ; Killick, Richard. / TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones. In: Journal of Neurochemistry. 2006 ; Vol. 99, No. 3. pp. 989-999.
@article{f16581fb790040cc9ee39785c8a44315,
title = "TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones",
abstract = "p73, like Notch, has been implicated in neurodevelopment and in the maintenance of the mature central nervous system. In this study, by the use of reporter-gene assays, we demonstrate that C-promoter binding factor-1 (CBF-1)-dependent gene transcription driven by the Notch-1 intracellular domain (N1ICD) is potently antagonized by exogenously expressed transactivating (TA) p73 splice variants in SH-SY5Y neuroblastomas and in primary neurones. Time course analysis indicated that the inhibitory effects of TAp73 are direct and are not mediated via the product of a downstream target gene. We found that endogenous TAp73 stabilized by either c-Abl or cisplatin treatment also potently antagonized N1ICD/CBF-1-dependent gene transcription. Furthermore, western blotting revealed that exogenous TAp73 suppressed endogenous hairy and enhancer of split-1 (HES-1) protein levels and antagonized the increase in HES-1 protein induced by exogenous N1ICD expression. Evidence of a direct physical interaction between N1ICD and TAp73α was demonstrated by co-immunoprecipitation. Using Notch deletion constructs, we demonstrate that TAp73α binds the N1ICD in a region C-terminal of aa 2094. Interestingly, ΔNp73α and TAp73αR292H also co-purified with N1ICD, but neither inhibited N1ICD/CBF-1-dependent transcription. This suggests that an intact transactivation (TA) domain and the ability to bind DNA are necessary for TAp73 to antagonize Notch signalling. Finally we found that TAp73α reversed the N1ICD-mediated repression of retinoic acid-induced differentiation of SH-SY5Y neuroblastomas, providing functional evidence for an inhibitory effect of TAp73α on notch signalling. Collectively, these findings may have ramifications for neurodevelopment, neurodegeneration and oncogenesis.",
keywords = "Development, Neurodegeneration, Notch, Oncogenesis, p53, p73",
author = "Claudie Hooper and Mahvash Tavassoli and Chapple, {J. Paul} and Dafe Uwanogho and Richard Goodyear and Gerry Melino and Simon Lovestone and Richard Killick",
year = "2006",
month = "11",
doi = "10.1111/j.1471-4159.2006.04142.x",
language = "English",
volume = "99",
pages = "989--999",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones

AU - Hooper, Claudie

AU - Tavassoli, Mahvash

AU - Chapple, J. Paul

AU - Uwanogho, Dafe

AU - Goodyear, Richard

AU - Melino, Gerry

AU - Lovestone, Simon

AU - Killick, Richard

PY - 2006/11

Y1 - 2006/11

N2 - p73, like Notch, has been implicated in neurodevelopment and in the maintenance of the mature central nervous system. In this study, by the use of reporter-gene assays, we demonstrate that C-promoter binding factor-1 (CBF-1)-dependent gene transcription driven by the Notch-1 intracellular domain (N1ICD) is potently antagonized by exogenously expressed transactivating (TA) p73 splice variants in SH-SY5Y neuroblastomas and in primary neurones. Time course analysis indicated that the inhibitory effects of TAp73 are direct and are not mediated via the product of a downstream target gene. We found that endogenous TAp73 stabilized by either c-Abl or cisplatin treatment also potently antagonized N1ICD/CBF-1-dependent gene transcription. Furthermore, western blotting revealed that exogenous TAp73 suppressed endogenous hairy and enhancer of split-1 (HES-1) protein levels and antagonized the increase in HES-1 protein induced by exogenous N1ICD expression. Evidence of a direct physical interaction between N1ICD and TAp73α was demonstrated by co-immunoprecipitation. Using Notch deletion constructs, we demonstrate that TAp73α binds the N1ICD in a region C-terminal of aa 2094. Interestingly, ΔNp73α and TAp73αR292H also co-purified with N1ICD, but neither inhibited N1ICD/CBF-1-dependent transcription. This suggests that an intact transactivation (TA) domain and the ability to bind DNA are necessary for TAp73 to antagonize Notch signalling. Finally we found that TAp73α reversed the N1ICD-mediated repression of retinoic acid-induced differentiation of SH-SY5Y neuroblastomas, providing functional evidence for an inhibitory effect of TAp73α on notch signalling. Collectively, these findings may have ramifications for neurodevelopment, neurodegeneration and oncogenesis.

AB - p73, like Notch, has been implicated in neurodevelopment and in the maintenance of the mature central nervous system. In this study, by the use of reporter-gene assays, we demonstrate that C-promoter binding factor-1 (CBF-1)-dependent gene transcription driven by the Notch-1 intracellular domain (N1ICD) is potently antagonized by exogenously expressed transactivating (TA) p73 splice variants in SH-SY5Y neuroblastomas and in primary neurones. Time course analysis indicated that the inhibitory effects of TAp73 are direct and are not mediated via the product of a downstream target gene. We found that endogenous TAp73 stabilized by either c-Abl or cisplatin treatment also potently antagonized N1ICD/CBF-1-dependent gene transcription. Furthermore, western blotting revealed that exogenous TAp73 suppressed endogenous hairy and enhancer of split-1 (HES-1) protein levels and antagonized the increase in HES-1 protein induced by exogenous N1ICD expression. Evidence of a direct physical interaction between N1ICD and TAp73α was demonstrated by co-immunoprecipitation. Using Notch deletion constructs, we demonstrate that TAp73α binds the N1ICD in a region C-terminal of aa 2094. Interestingly, ΔNp73α and TAp73αR292H also co-purified with N1ICD, but neither inhibited N1ICD/CBF-1-dependent transcription. This suggests that an intact transactivation (TA) domain and the ability to bind DNA are necessary for TAp73 to antagonize Notch signalling. Finally we found that TAp73α reversed the N1ICD-mediated repression of retinoic acid-induced differentiation of SH-SY5Y neuroblastomas, providing functional evidence for an inhibitory effect of TAp73α on notch signalling. Collectively, these findings may have ramifications for neurodevelopment, neurodegeneration and oncogenesis.

KW - Development

KW - Neurodegeneration

KW - Notch

KW - Oncogenesis

KW - p53

KW - p73

UR - http://www.scopus.com/inward/record.url?scp=33750058825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750058825&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2006.04142.x

DO - 10.1111/j.1471-4159.2006.04142.x

M3 - Article

C2 - 17076661

AN - SCOPUS:33750058825

VL - 99

SP - 989

EP - 999

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -